02.07.2013 • News

Neville Prior Elected as Fecc VP

Dr. Neville Prior, Chairman of the Cornelius Group, has been elected as Vice...
Dr. Neville Prior, Chairman of the Cornelius Group, has been elected as Vice President of the European Association of Chemical Distributors (Fecc).

Cornelius Group Chairman Dr. Neville Prior has been elected as vice president of the The European Association of Chemical Distributors (Fecc). Gordon Hay, Brenntag's operations director Europe and Giorgio Bonetti, member of the governing and executive council of the Italian Association of Chemical Trade (AssICC) were appointed by the Fecc general assembly as members of the Fecc board.

"At a time of economic uncertainty in Europe and around the world, the chemical distribution industry delivers innovative and cost effective products and services to industry," Prior said. "I want to see Fecc continue to work with National Associations and company members to ensure that our industry will remain in that position for the future."   

Dr. Prior is member of the Fecc Board since 2009, actively contributing to the success of the association activities. Prior is also President of the Chemical Business Association (CBA) and brings 25 years of experience in the chemical distribution industry. Fecc's President Edgar E. Nordmann welcomed Dr. Prior and thanked the departing Vice President, Dr. Enea Marchesi for his leadership and service.

The general assembly also ratified the membership application of Evonik, Cornelius Group and DKSH as new company members. Fecc now brings together a total of 36 company members, as well as 15 national associations and 11 associate members.


 

 

 

Company

Logo:

FECC - European Association of Chemical Distributors

Rue du Luxembourg 16B
1000 Brussels, Belgium
Belgium

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.